Want to see CTKB full AI Analyst Report?
Cytek Biosciences (CTKB) Ownership Overview
8.47% Insiders
11.74% Mutual Funds
0.04% Other Institutional Investors
12.37% ETFs
67.37% Public Companies and
Individual Investors
The ownership structure of Cytek Biosciences (CTKB) stock is a mix of institutional, retail, and individual investors. Approximately 24.16% of the company’s stock is owned by Institutional Investors, 8.47% is owned by Insiders, and 67.37% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $9221395 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $101319 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,935,455 | Institution | 4.57% | 37,393,367 | |
| 5,573,408 | Institution | 4.29% | 35,112,470 | |
| 5,561,029 | Insider | 4.28% | 35,034,483 | |
| 4,826,168 | Institution | 3.71% | 30,404,858 | |
| 4,821,870 | Insider | 3.71% | 30,377,781 | |
| 2,081,579 | Institution | 1.60% | 13,113,948 | |
| 1,556,994 | Institution | 1.20% | 9,809,062 | |
| 1,516,993 | Institution | 1.17% | 9,557,056 | |
| 1,254,985 | Institution | 0.97% | 7,906,406 | |
| 945,719 | Institution | 0.73% | 5,958,030 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,826,168 | Institution | 3.71% | 30,404,858 | |
| 1,516,993 | Institution | 1.17% | 9,557,056 | |
| 1,254,985 | Institution | 0.97% | 7,906,406 | |
| 945,719 | Institution | 0.73% | 5,958,030 | |
| 853,949 | Institution | 0.66% | 5,379,879 | |
| 832,377 | Institution | 0.64% | 5,243,975 | |
| 819,456 | Institution | 0.63% | 5,162,573 | |
| 642,661 | Institution | 0.49% | 4,048,764 | |
| 572,392 | Institution | 0.44% | 3,606,070 | |
| 515,620 | Institution | 0.40% | 3,248,406 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,525,848 | Institution | 2.71% | 21,014,054 | |
| 3,092,485 | Institution | 2.38% | 18,987,858 | |
| 1,247,322 | Institution | 0.96% | 7,434,039 | |
| 1,137,517 | Institution | 0.88% | 6,984,354 | |
| 947,098 | Institution | 0.73% | 5,966,717 | |
| 857,279 | Institution | 0.66% | 5,263,693 | |
| 800,191 | Institution | 0.62% | 4,913,173 | |
| 707,815 | Institution | 0.54% | 4,218,577 | |
| 600,923 | Institution | 0.46% | 3,689,667 | |
| 551,914 | Institution | 0.42% | 3,388,752 |
FAQ
Who Owns Cytek Biosciences (CTKB)?
According to the latest TipRanks data, approximately 0.04% of the company's stock is held by institutional investors, 8.47% is held by insiders, and 67.37% is held by retail investors.
What percentage of Cytek Biosciences (CTKB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.04% of Cytek Biosciences (CTKB) stock is held by institutional investors.
What percentage of Cytek Biosciences (CTKB) stock is held by retail investors?
According to the latest TipRanks data, approximately 67.37% of Cytek Biosciences (CTKB) stock is held by retail investors.
Who owns the most shares of Cytek Biosciences (CTKB)?
Vanguard owns the most shares of Cytek Biosciences (CTKB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.